Evidence map›Paper›PMID 39963282›Full record

ArticleFrontiers in endocrinology2025

Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases.

Sadegh Mousavi, Katja Bieber, Henner Zirpel, Artem Vorobyev, Henning Olbrich, Cristian Papara, David A De Luca, Diamant Thaci, Enno Schmidt, Gabriele Riemekasten and 4 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sadegh Mousavi *Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Katja Bieber *Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Henner Zirpel *Institute and Comprehensive Centre for Inflammatory Medicine, University of Lübeck, Lübeck, Germany.
Artem VorobyevDepartment of Dermatology, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany.
Henning OlbrichDepartment of Dermatology, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany.
Cristian PaparaLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
David A De LucaLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Diamant ThaciInstitute and Comprehensive Centre for Inflammatory Medicine, University of Lübeck, Lübeck, Germany.
Enno SchmidtLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Gabriele RiemekastenDepartment of Rheumatology and Clinical Immunology, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany.
Peter LamprechtDepartment of Rheumatology and Clinical Immunology, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany.
Matthias LaudesInstitute of Diabetes and Clinical Metabolic Research, University of Kiel, Kiel, Germany.
Khalaf Kridin *Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Ralf J LudwigLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Overweight and obesity are a global pandemic, contributing to death and disability-adjusted life-years. Obesity is a major factor in the onset of chronic inflammatory diseases (CIDs). Yet, several knowledge gaps remain: For several CIDs, inconsistent results have been reported, relating to their obesity-imposed risk, data on most rare CIDs remain unavailable, sex differences and racial disparities remain mostly unaddressed. Methods: A large-scale cohort study compared the risk of developing 46 CIDs in individuals with overweight/obesity (n=3,101,824) to an equal number of non-overweight/obese individuals. Propensity score matching optimized between-group comparability, and sensitivity analyses assessed study robustness. Results: The risk of developing any CID was 28.48% in overweight/obese individuals versus 17.55% in non-overweight/obese controls, with a hazard ratio (95%-confidence interval) of 1.52 (1.509-1.521, p<0.0001). This risk was consistent across all sensitivity, sex-, and race-stratified analyses. Overweight and obesity were associated with an increased risk for 24 of 46 CIDs in the primary analysis and all sensitivity analyses. For 12 diseases, increased risks were confirmed to one of the two sensitivity analyses, while for 10 diseases, results were discordant. No increased risk was observed for one disease. In sex-stratified analysis, overweight and obesity posed a more pronounced risk for four CIDs in female individuals. In race-stratified analysis, overweight and obesity were linked to a higher risk for seven CIDs in White individuals and to one CID in "Black or African American" individuals. Conclusion: Overweight and obesity increase the risk for the majority of CIDs in a sex- and race-specific manner.

Indexed as

InflammationNoncommunicable DiseasesObesityAdultAgedChronic DiseaseCohort StudiesFemaleHumansMaleMiddle AgedOverweightRisk Factorscohort studyinflammationobesityracial disparitiesrisksex differences

Identifiers

PMID39963282
PMCPMC11830592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.